Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00179660
Status:
COMPLETED
Last Update Posted:
2016-01-21
First Post:
2005-09-13
Brief Title:
Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkins Lymphoma NHL
Sponsor:
Celgene Corporation
Organization:
Celgene